Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
6.975 USD | -4.84% | -9.74% | -38.22% |
May. 23 | Transcript : Altimmune, Inc. Presents at UBS Obesity Therapeutics Day, May-23-2024 10:00 AM | |
May. 09 | Transcript : Altimmune, Inc., Q1 2024 Earnings Call, May 09, 2024 |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-38.22% | 520M | |
+9.74% | 118B | |
+10.44% | 106B | |
-11.01% | 23.4B | |
-1.69% | 22.1B | |
-10.23% | 18.34B | |
-41.92% | 16.59B | |
-15.66% | 15.97B | |
+6.91% | 14.03B | |
+17.43% | 11.67B |
- Stock Market
- Equities
- ALT Stock
- News Altimmune, Inc.
- Guggenheim Downgrades Altimmune to Neutral From Buy